Highlights:
• $12.9M revenue already contracted for FY20; 16% increase on Q1 FY19;
• $2.5M of new contracts sold in Q1, adding $1.2M revenue to be recognised in FY20;
• Total sold revenue out to FY25 is $34.0M;
• Strategically important contract signed with Healthscope - first sale to a major private hospital
group of our data and analytics capabilities;
• Cash surplus from operations of $136K for Q1 FY20; representing the third consecutive quarter
of positive net cashflow; and improved cash reserves of $4.4M
ALC Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
